Agagunduz D, Cocozza E, Cemali O, Bayazit A, Nani M, Cerqua I
Front Pharmacol. 2023; 14:1130562.
PMID: 36762108
PMC: 9903080.
DOI: 10.3389/fphar.2023.1130562.
Madella A, van Bergenhenegouwen J, Garssen J, Masereeuw R, Overbeek S
Toxins (Basel). 2022; 14(9).
PMID: 36136583
PMC: 9505404.
DOI: 10.3390/toxins14090645.
Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T
Pathogens. 2019; 8(3).
PMID: 31412603
PMC: 6789542.
DOI: 10.3390/pathogens8030126.
MSadeq S, Wu S, Swick R, Choct M
Anim Nutr. 2018; 1(1):1-11.
PMID: 29766984
PMC: 5884463.
DOI: 10.1016/j.aninu.2015.02.004.
Matijasic M, Mestrovic T, Peric M, Paljetak H, Panek M, Bender D
Int J Mol Sci. 2016; 17(4).
PMID: 27104515
PMC: 4849034.
DOI: 10.3390/ijms17040578.
Probiotics and Synbiotics Decrease Postoperative Sepsis in Elective Gastrointestinal Surgical Patients: a Meta-Analysis.
Arumugam S, Lau C, Chamberlain R
J Gastrointest Surg. 2016; 20(6):1123-31.
PMID: 27073082
DOI: 10.1007/s11605-016-3142-y.
The Efficacy of Probiotic (Lactobacillus rhamnosus GG) and 5-ASA (Aminosalicylic Acid) in the Treatment of Experimental Radiation Proctitis in Rats.
Dandin O, Akin M, Balta A, Yucel E, Karakas D, Demirbas S
Indian J Surg. 2016; 77(Suppl 2):563-9.
PMID: 26730065
PMC: 4692951.
DOI: 10.1007/s12262-013-0923-3.
Conservative treatment for anal incontinence.
Carter D
Gastroenterol Rep (Oxf). 2014; 2(2):85-91.
PMID: 24759347
PMC: 4020129.
DOI: 10.1093/gastro/gou013.
A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms.
Kalman D, Schwartz H, Alvarez P, Feldman S, Pezzullo J, Krieger D
BMC Gastroenterol. 2009; 9:85.
PMID: 19922649
PMC: 2784472.
DOI: 10.1186/1471-230X-9-85.
Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health.
Mai V, Draganov P
World J Gastroenterol. 2008; 15(1):81-5.
PMID: 19115471
PMC: 2653298.
DOI: 10.3748/wjg.15.81.
The dual role of bacteriocins as anti- and probiotics.
Gillor O, Etzion A, Riley M
Appl Microbiol Biotechnol. 2008; 81(4):591-606.
PMID: 18853155
PMC: 2670069.
DOI: 10.1007/s00253-008-1726-5.
Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.
Damaskos D, Kolios G
Br J Clin Pharmacol. 2008; 65(4):453-67.
PMID: 18279467
PMC: 2291386.
DOI: 10.1111/j.1365-2125.2008.03096.x.
Are probiotics detectable in human feces after oral uptake by healthy volunteers?.
Prilassnig M, Wenisch C, Daxboeck F, Feierl G
Wien Klin Wochenschr. 2007; 119(15-16):456-62.
PMID: 17721765
DOI: 10.1007/s00508-007-0808-1.
Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.
Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger T, Stange E, Fellermann K
Infect Immun. 2007; 75(5):2399-407.
PMID: 17283097
PMC: 1865783.
DOI: 10.1128/IAI.01563-06.
Probiotics for preventing preterm labour.
Othman M, Neilson J, Alfirevic Z
Cochrane Database Syst Rev. 2007; (1):CD005941.
PMID: 17253567
PMC: 9006117.
DOI: 10.1002/14651858.CD005941.pub2.
[Dietary fibre: more than a matter of dietetics. I. Compounds, properties, physiological effects].
Trepel F
Wien Klin Wochenschr. 2004; 116(14):465-76.
PMID: 15379141
DOI: 10.1007/BF03040941.
Randomised clinical trial of synbiotic therapy in elective surgical patients.
Anderson A, McNaught C, Jain P, MacFie J
Gut. 2004; 53(2):241-5.
PMID: 14724157
PMC: 1774935.
DOI: 10.1136/gut.2003.024620.
Bio-ecological control of perioperative and ITU morbidity.
Bengmark S
Langenbecks Arch Surg. 2003; 389(2):145-54.
PMID: 14605886
DOI: 10.1007/s00423-003-0425-z.
Intestinal microflora as a therapeutic target in inflammatory bowel disease.
Mitsuyama K, Toyonaga A, Sata M
J Gastroenterol. 2003; 37 Suppl 14:73-7.
PMID: 12572870
DOI: 10.1007/BF03326418.
The clear liquid diet: when is it appropriate?.
Hancock S, Cresci G, Martindale R
Curr Gastroenterol Rep. 2002; 4(4):324-31.
PMID: 12149178
DOI: 10.1007/s11894-002-0083-2.